← All candidates
58 insider filings on record.
58 filings on record.
ADMAADMA BIOLOGICS, INC.
NasdaqGM · Healthcare · $2.15B
$9.62
+0.42% · Sep 4
58 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · dailyNo open-market activity in range
▸ hover a marker for the filing · drag to zoom · 1 move explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$2.15B
Float
219.7M
98% public
Short % float
Pro
Price / profit
13.7
Price / future profit
9.8
Price / sales
4.2
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
53 more transactions on Pro →Context
Wall St
$17.00 avg target
+76.7% vs today · 5 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
The file stays open
58 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice